WallStSmart

The Clorox Company (CLX)vsKenvue Inc. (KVUE)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Kenvue Inc. generates 129% more annual revenue ($15.41B vs $6.72B). KVUE leads profitability with a 10.8% profit margin vs 8.7%. CLX appears more attractively valued with a PEG of 1.17. KVUE earns a higher WallStSmart Score of 60/100 (C).

CLX

Buy

53

out of 100

Grade: C-

Growth: 2.0Profit: 7.5Value: 4.7Quality: 3.3
Piotroski: 2/9

KVUE

Buy

60

out of 100

Grade: C

Growth: 4.7Profit: 7.0Value: 4.7Quality: 5.0
Piotroski: 4/9Altman Z: 1.22
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CLXSignificantly Overvalued (-24.4%)

Margin of Safety

-24.4%

Fair Value

$101.26

Current Price

$87.76

$13.50 premium

UndervaluedFair: $101.26Overvalued
KVUESignificantly Overvalued (-86.5%)

Margin of Safety

-86.5%

Fair Value

$9.94

Current Price

$17.78

$7.84 premium

UndervaluedFair: $9.94Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CLX1 strengths · Avg: 10.0/10
Return on EquityProfitability
652.2%10/10

Every $100 of equity generates 652 in profit

KVUE0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

CLX4 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Price/BookValuation
118.6x2/10

Trading at 118.6x book value

Revenue GrowthGrowth
-2.0%2/10

Revenue declined 2.0%

EPS GrowthGrowth
-50.1%2/10

Earnings declined 50.1%

KVUE2 concerns · Avg: 3.0/10
Revenue GrowthGrowth
3.0%4/10

3.0% revenue growth

Altman Z-ScoreHealth
1.222/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : CLX

The strongest argument for CLX centers on Return on Equity. PEG of 1.17 suggests the stock is reasonably priced for its growth.

Bull Case : KVUE

PEG of 1.49 suggests the stock is reasonably priced for its growth.

Bear Case : CLX

The primary concerns for CLX are Piotroski F-Score, Price/Book, Revenue Growth. Debt-to-equity of 61.33 is elevated, increasing financial risk.

Bear Case : KVUE

The primary concerns for KVUE are Revenue Growth, Altman Z-Score.

Key Dynamics to Monitor

CLX carries more volatility with a beta of 0.54 — expect wider price swings.

KVUE is growing revenue faster at 3.0% — sustainability is the question.

KVUE generates stronger free cash flow (549M), providing more financial flexibility.

Monitor HOUSEHOLD & PERSONAL PRODUCTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

KVUE scores higher overall (60/100 vs 53/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

The Clorox Company

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

The Clorox Company, based in Oakland, California, is an American global manufacturer and marketer of consumer and professional products.

Kenvue Inc.

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Kenvue Inc. is a consumer health company globally.

Visit Website →

Want to dig deeper into these stocks?